Protection Against Cisplatin-Induced Nephrotoxicity by Recombinant Human Erythropoietin

By Yalcin Suayib   Müftüoùglu Sevda   Cetúõn Eren   Süarer Banu   Yildirim Berna Akkusü   Zeybek Dúõlara   Orhan Bülent  

Medical Oncology, Vol. 20, Iss. 2, 2003-06 ,pp. : 169-174

Humana Press, Inc

Access to resources Recommend Favorite

Grape seed proanthocyanidin extract protects from cisplatin-induced nephrotoxicity by inhibiting endoplasmic reticulum stress-induced apoptosis

By              

Molecular Medicine Reports, Vol. 9, Iss. 3, 2014-01 ,pp. : 801-807

Spandidos Publications

Access to resources Recommend Favorite

Large volume loading to prevent cisplatin-induced nephrotoxicity during negative-balance isolated pelvic perfusion

By Nakazato Keiko   Kim Chol   Terajima Katsuyuki   Murata Satoru   Fujitani Hitoshi   Nakanishi Kazuhiro   Tajima Hiroyuki   Kumazaki Tatsuo   Sakamoto Atsuhiro  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 10, 2007-10 ,pp. : 741-747

Springer Publishing Company

Access to resources Recommend Favorite

ELR-CXC chemokine antagonism and cisplatin co-treatment additively reduce H22 hepatoma tumor progression and ameliorate cisplatin-induced nephrotoxicity

By                  

Oncology Reports, Vol. 31, Iss. 4, 2014-01 ,pp. : 1599-1604

Spandidos Publications

Access to resources Recommend Favorite

G31P, CXCR1/2 inhibitor, with cisplatin inhibits the growth of mice hepatocellular carcinoma and mitigates highdose cisplatin-induced nephrotoxicity

By  

Oncology Reports, Vol. 33, Iss. 2, 2015-01 ,pp. : 751-757

Spandidos Publications

Access to resources Recommend Favorite